ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VMI vs TMO // OPERATING MARGIN

Valmont Industries Inc. (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: VMI 6 — TMO 7
▲ OPERATING MARGIN LEADER: TMO
operating-margins
10.10%
operating-margins
17.40%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VMI VS. TMO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VMI TMO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 30.20% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) 14.70% 9.30% +5.40 VMI /roic <GO>
EV/EBITDA & P/E Valuation 16.5x 30.4x -13.90 VMI /valuation <GO>
Free Cash Flow Yield 3.76% 2.40% +1.36 VMI /fcf-yield <GO>
Operating Margin ACTIVE 10.10% 17.40% -7.30 TMO /operating-margins <GO>
Net Profit Margin 8.50% 15.10% -6.60 TMO /net-margins <GO>
Revenue Growth (YoY) 0.70% 3.90% -3.20 TMO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.63% 0.24% +0.39 VMI /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.17 4.50 +1.67 VMI /balance-sheet <GO>
Piotroski F-Score Quality 7/9 8/9 -1.00 TMO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 38.8 62.9 -24.10 TMO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.90 0.94 -0.04 TMO /macro-sensitivity <GO>
Forward P/E Multiple 21.9x 36.3x -14.40 VMI /forward-pe <GO>
Enterprise Scale & Market Cap $8.28B $262.22B -$253.93B TMO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VMI REV TMO REV VMI GROSS % TMO GROSS % VMI FCF TMO FCF
FY 2025 $4.10B $44.56B 30.2% — $311.4M $6.29B
FY 2024 $4.08B $42.88B 30.5% — $493.2M $7.27B
FY 2023 $4.17B $42.86B — — $118.9M $6.48B
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VMI // BETA 0.90
TMO // BETA 0.94